Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals

por Kurshan, Ashwini, Snell, Luke B, Prior, Lucie, Tam, Jerry C H, Graham, Carl, Thangarajah, Rajeni, Edgeworth, Jonathan D, Nebbia, Gaia, Doores, Katie J
Publicado 2023

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection

por Seow, Jeffrey, Shalim, Zayed A., Graham, Carl, Kimuda, Simon, Pillai, Aswin, Lechmere, Thomas, Kurshan, Ashwini, Khimji, Atika M., Snell, Luke B., Nebbia, Gaia, Mant, Christine, Waters, Anele, Fox, Julie, Malim, Michael H., Doores, Katie J.
Publicado 2023

The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern

por Graham, Carl, Lechmere, Thomas, Rehman, Aisha, Seow, Jeffrey, Kurshan, Ashwini, Huettner, Isabella, Maguire, Thomas J. A., Tam, Jerry C. H., Cox, Daniel, Ward, Christopher, Racz, Mariusz, Waters, Anele, Mant, Christine, Malim, Michael H., Fox, Julie, Doores, Katie J.
Publicado 2022

Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with Cancer

por McKenzie, Duncan R., Graham, Rosalind, Lechmere, Thomas, Domingo-Vila, Clara, Alaguthurai, Thanussuyah, Arman, Celeste, Pollock, Emily, Gousis, Charalampos, Kakkassery, Helen, Carpenter, Esme, Kurshan, Ashwini, Vidler, Jennifer, Kulasekararaj, Austin, Patten, Piers, North, Bernard V., Tree, Timothy, Doores, Katie J., Hayday, Adrian C., Irshad, Sheeba
Publicado 2022

Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders

por Harrington, Patrick, Kurshan, Ashwini, Delord, Marc, Lechmere, Thomas, Sheikh, Amna, Saunders, Jamie, Saha, Chandan, Dillon, Richard, Woodley, Claire, Asirvatham, Susan, Curto-Garcia, Natalia, Sullivan, Jennifer O’, Kordasti, Shahram, Radia, Deepti, McLornan, Donal, Malim, Michael H., Harrison, Claire, Doores, Katie J., de Lavallade, Hugues
Publicado 2022